Frontiers in Pharmacology, 2022 · DOI: 10.3389/fphar.2022.881195 · Published: June 27, 2022
After spinal cord injury, astrocyte scars form, limiting damage spread but hindering axon regeneration. The study explores fine-tuning scar formation to balance these effects. By using pexidartinib to continually delete microglia in a mouse model of spinal cord injury, the researchers found that astrocyte scars became less compacted. This looser scar structure allowed for improved axon regeneration and extension, suggesting a novel approach for spinal cord injury treatment.
Microglia modulation could serve as a therapeutic target for spinal cord injury by altering astrocyte scar formation.
Loosening astrocyte scars through microglia deletion may enhance axon regeneration in SCI patients.
CSF1R inhibitors, like pexidartinib, could be explored for clinical applications to improve functional recovery after SCI.